Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID M OMALLEY

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1609819424
CMS profile
299284
Location
HILLIARD, OH

General Payments · PY2018–2024

$507,866.21

  • Reported across 431 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$122,974.84

75 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $19,434.66 6
ABBVIE INC. $18,589.20 16
Genmab U.S., Inc. $17,758.21 8
Merck Sharp & Dohme Corporation $12,778.49 11
PFIZER INC. $11,115.95 3
BeiGene USA, Inc. $7,150.00 2
Acerta Pharma LLC $6,992.23 7
GlaxoSmithKline, LLC. $6,800.00 3
Corcept Therapeutics $6,752.76 7
Regeneron Pharmaceuticals, Inc. $3,708.36 3
EISAI INC. $3,225.00 2
Novocure Inc. $3,200.00 1
BioNTech SE $2,200.00 1
Eli Lilly and Company $1,800.00 1
Aadi Bioscience, Inc. $1,399.98 3
Incyte Corporation $70.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $26,683.44 46
PY2019 $65,037.86 68
PY2020 $73,197.09 50
PY2021 $59,366.78 45
PY2022 $79,695.63 78
PY2023 $80,910.57 69
PY2024 $122,974.84 75

Payment records · PY2024 (75)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $99.98 03/15/2024 Food and Beverage Undisputed 01/23/2026 1119596625 CMS
Aadi Bioscience, Inc. $450.00 05/16/2024 Consulting Fee Undisputed 01/23/2026 1119596629 CMS
Aadi Bioscience, Inc. $850.00 09/27/2024 Consulting Fee Undisputed 01/23/2026 1119596627 CMS
ABBVIE INC. $21.17 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105141784 CMS
ABBVIE INC. $169.38 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105141786 CMS
ABBVIE INC. $338.20 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1105141788 CMS
ABBVIE INC. $44.18 06/18/2024 Food and Beverage Undisputed 01/23/2026 1105141790 CMS
ABBVIE INC. $86.58 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105141792 CMS
ABBVIE INC. $2,100.00 07/16/2024 Consulting Fee Undisputed 01/23/2026 1105141794 CMS
ABBVIE INC. $2,450.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 1105141796 CMS
ABBVIE INC. $2,800.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 1105141798 CMS
ABBVIE INC. $2,000.00 08/09/2024 Travel and Lodging Undisputed 01/23/2026 1105141800 CMS
ABBVIE INC. $455.75 10/25/2024 Travel and Lodging Undisputed 01/23/2026 1105141802 CMS
ABBVIE INC. $34.98 10/25/2024 Food and Beverage Undisputed 01/23/2026 1105141804 CMS
ABBVIE INC. $48.98 10/25/2024 Food and Beverage Undisputed 01/23/2026 1105141806 CMS
ABBVIE INC. $14.99 10/25/2024 Food and Beverage Undisputed 01/23/2026 1105141808 CMS
ABBVIE INC. $14.99 10/25/2024 Food and Beverage Undisputed 01/23/2026 1105141810 CMS
ABBVIE INC. $7,975.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 1105141812 CMS
ABBVIE INC. $35.00 11/11/2024 Travel and Lodging Undisputed 01/23/2026 1105141814 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1104385021 CMS
AstraZeneca Pharmaceuticals LP $96.06 04/24/2024 Food and Beverage Undisputed 01/23/2026 1104391749 CMS
AstraZeneca Pharmaceuticals LP $30.24 06/02/2024 Food and Beverage Undisputed 01/23/2026 1104278567 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 06/13/2024 Consulting Fee Undisputed 01/23/2026 1105569635 CMS
AstraZeneca Pharmaceuticals LP $2,740.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1104362619 CMS
AstraZeneca Pharmaceuticals LP $15.93 08/30/2024 Food and Beverage Undisputed 01/23/2026 1105770992 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1105644338 CMS
BeiGene USA, Inc. $1,950.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1120866990 CMS
BeiGene USA, Inc. $5,200.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1120866992 CMS
BioNTech SE $2,200.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 1150660516 CMS
Corcept Therapeutics $2,600.00 06/01/2024 Consulting Fee Undisputed 01/23/2026 1117746138 CMS
Corcept Therapeutics $139.11 06/01/2024 Food and Beverage Undisputed 01/23/2026 1117746140 CMS
Corcept Therapeutics $45.82 06/01/2024 Food and Beverage Undisputed 01/23/2026 1117746142 CMS
Corcept Therapeutics $1,300.00 08/12/2024 Consulting Fee Undisputed 01/23/2026 1117746148 CMS
Corcept Therapeutics $1,950.00 09/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117746208 CMS
Corcept Therapeutics $67.83 09/12/2024 Food and Beverage Undisputed 01/23/2026 1117746210 CMS
Corcept Therapeutics $650.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1117746236 CMS
Daiichi Sankyo Inc. $293.12 06/21/2024 Travel and Lodging Undisputed 01/23/2026 1089464460 CMS
Daiichi Sankyo Inc. $12,890.00 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1089464458 CMS
Daiichi Sankyo Inc. $16.11 06/22/2024 Food and Beverage Undisputed 01/23/2026 1089464462 CMS
Daiichi Sankyo Inc. $35.43 06/22/2024 Food and Beverage Undisputed 01/23/2026 1089464464 CMS
Daiichi Sankyo Inc. $1,860.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1089464454 CMS
Daiichi Sankyo Inc. $4,340.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 1089464456 CMS
Eisai Inc. $780.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1110740381 CMS
Eisai Inc. $2,445.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1110740383 CMS
Eli Lilly and Company $1,800.00 02/05/2024 Consulting Fee Undisputed 01/23/2026 1136132972 CMS
Genmab U.S., Inc. $131.82 09/14/2024 Food and Beverage Undisputed 01/23/2026 1126825825 CMS
Genmab U.S., Inc. $18.26 10/19/2024 Food and Beverage Undisputed 01/23/2026 1126825827 CMS
Genmab U.S., Inc. $7.82 10/19/2024 Food and Beverage Undisputed 01/23/2026 1126825831 CMS
Genmab U.S., Inc. $4,000.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 1126825829 CMS
Genmab U.S., Inc. $7,321.31 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1126825837 CMS
Genmab U.S., Inc. $622.21 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1126825833 CMS
Genmab U.S., Inc. $56.79 12/14/2024 Food and Beverage Undisputed 01/23/2026 1126825835 CMS
Genmab U.S., Inc. $5,600.00 12/14/2024 Consulting Fee Undisputed 01/23/2026 1126825839 CMS
GlaxoSmithKline, LLC. $1,600.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1116037778 CMS
GlaxoSmithKline, LLC. $2,400.00 03/26/2024 Consulting Fee Undisputed 01/23/2026 1116677531 CMS
GlaxoSmithKline, LLC. $2,800.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1116194192 CMS
Incyte Corporation $70.00 10/15/2024 Food and Beverage Undisputed 01/23/2026 1141323197 CMS
Merck Sharp & Dohme LLC $2,440.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1141801182 CMS
Merck Sharp & Dohme LLC $2,117.50 06/19/2024 Consulting Fee Undisputed 01/23/2026 1141801186 CMS
Merck Sharp & Dohme LLC $467.46 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1141683915 CMS
Merck Sharp & Dohme LLC $247.47 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1141683919 CMS
Merck Sharp & Dohme LLC $55.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141683911 CMS
Merck Sharp & Dohme LLC $288.33 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141683913 CMS
Merck Sharp & Dohme LLC $208.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141683917 CMS
Merck Sharp & Dohme LLC $48.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141865249 CMS
Merck Sharp & Dohme LLC $45.98 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141865725 CMS
Merck Sharp & Dohme LLC $150.00 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1141801180 CMS
Merck Sharp & Dohme LLC $6,710.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 1141801184 CMS
Novocure Inc. $3,200.00 07/11/2024 Honoraria Undisputed 01/23/2026 1119257632 CMS
PFIZER INC. $55.93 06/05/2024 Food and Beverage Undisputed 01/23/2026 1131477138 CMS
PFIZER INC. $180.02 06/05/2024 Travel and Lodging Undisputed 01/23/2026 1131477142 CMS
PFIZER INC. $10,880.00 06/05/2024 Honoraria Undisputed 01/23/2026 1131477146 CMS
Regeneron Pharmaceuticals, Inc. $99.36 06/02/2024 Food and Beverage Undisputed 01/23/2026 1114403059 CMS
Regeneron Pharmaceuticals, Inc. $802.00 09/20/2024 Consulting Fee Undisputed 01/23/2026 1114403061 CMS
Regeneron Pharmaceuticals, Inc. $2,807.00 09/20/2024 Consulting Fee Undisputed 01/23/2026 1114403063 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.